BioSpace News Archive

NeuroTrauma Sciences, LLC (NTS), a private biopharmaceutical company developing a portfolio of disease-modifying therapeutic candidates to treat the devastating effects of traumatic brain injury (TBI), today provided an update on the development of its lead drug candidates NTS-104 and NTS-105 in traumatic brain injury.

Invacare Corporation announced that Matt Monaghan, chairman, president and chief executive officer, will present at the 12th Annual East Coast IDEAS Investor Conference on Wednesday, June 22, 2022.

Clinical laboratory tests refer to various medical tests performed in a laboratory to gain information about the health condition of a patient by using their blood or urine samples.

According to the latest report by Reports and Data, the global dental imaging market size was USD 2.54 Billion in 2020 and is expected to reach USD 4.88 Billion in 2028 and register a revenue CAGR of 8.4% during the forecast period, 2021-2028.

Coya Therapeutics, Inc. (Coya), a clinical-stage biotechnology company developing multiple first-in-class and best-in-class approaches that enhance regulatory T cell (Treg) function, today announced that it has raised approximately $10.3 million from institutional and accredited investors.

The industry analysis report is considered a valuable source of information about the global Renal Cell Cancer Treatment industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

The latest market analysis report published by Reports and Data, titled ‘Global Nasal Antihistamines Market – Forecast to 2028,’ thoroughly examines the Nasal Antihistamines industry to provide essential data & information for the targeted readers. The report consists of quantitative and qualitative research on the market performed by our market experts

The global robotic prosthetic market size is expected to reach USD 2,384.4 Million in 2028 and register a revenue CAGR of 8.9% over the forecast period, according to latest report by Reports and Data. Emergence of mind-controlled humonics is considered one of the most important factors to impact market revenue growth.

The global thyroid function tests market size is expected to reach USD 2.44 Billion by 2028 at a CAGR of 6.2%, according to the latest report by Reports and Data.

Immunomic Therapeutics, Inc., a privately-held clinical-stage biotechnology company pioneering the study of LAMP -mediated nucleic acid-based immunotherapy announced the appointment of Brian Stamper to Vice President, Cell Therapy Operations.